Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study (vol 19, pg 728, 2019)

首页> 外文期刊>The Lancet infectious diseases >Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study (vol 19, pg 728, 2019)

【24h】

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study (vol 19, pg 728, 2019)

机译：日常生活的成本效益和竞选伤前度在Gavi符合条件的国家/地区的疫苗疫苗：一个建模研究（Vol 19，PG 728,2019）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Lancet infectious diseases》 |2020年第5期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献

1. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study (vol 19, pg 728, 2019) [J] . The Lancet infectious diseases . 2020,第5期

机译：日常生活的成本效益和竞选伤前度在Gavi符合条件的国家/地区的疫苗疫苗：一个建模研究（Vol 19，PG 728,2019）
2. Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study [J] . Nathan C. Lo, Ribhav Gupta, Jeffrey D. Stanaway, The Journal of Infectious Diseases . 2018,第Suppla4期

机译：VI缀合物疫苗对抗伤寒症的策略和发病率的比较：一种成本效益建模研究
3. Typhoid Vaccines as Routine Public Health Tools for Developing Countries: An Idea Whose Time Has Come [J] . J.Clemens International journal of infectious diseases : . 2008,第Supplementa1期

机译：伤寒疫苗作为发展中国家的例行公共卫生工具：时代到来了
4. A-share Stock Reactions to the Approval of COVID-19 Vaccine Clinical Trial: An Event Study Model of Listed Pharmaceutical Firms’ Returns [C] . Xiong Kewei, Liang Yuanyuan International Conference on Economic Management and Model Engineering . 2020

机译：A股股票反应对Covid-19疫苗临床试验的批准：列出的制药公司回报的事件研究模式
5. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study [O] . Joke Bilcke, Marina Antillón, Zoë Pieters, -1

机译：在符合加维资格的国家中常规和运动性使用伤寒Vi-结合疫苗的成本效益：模型研究
6. PIN34 - COMPARING THE ESTIMATED PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PHID-CV AND PCV-13 IN THE ROUTINE IMMUNISATION PROGRAMME IN GAVI-ELIGIBLE COUNTRIES (SUB-SAHARAN AFRICA AND ASIA/OCEANIA): A MODELLING STUDY [O] . C. Sauboin, J.C. Vargas-Zambrano, A. Marijam, 2018

机译：PIN34 - 将Phid-CV和PCV-13的估计公共健康影响和成本效益与Gavi-符合条件的国家（撒哈拉以南非洲和亚洲/大洋洲）的常规免疫计划进行比较：一个建模研究

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study (vol 19, pg 728, 2019)

著录项

相似文献

相关主题

期刊订阅